GlassScriptPhysician profile
Ashok K Mehta
NPI 1114961596
$1,200.40
in general payments reported to CMS, 2019-2025
26 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $115 · 2021: $98.09 · 2022: $269 · 2023: $214 · 2024: $177 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $303.69 | 2022-2025 | |
| Novo Nordisk INC | $109.87 | 2019-2023 | Ozempic, Rybelsus |
| Shield Therapeutics INC | $69.29 | 2023-2024 | |
| Insulet Corporation | $67.67 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.19 | 2019-2025 | Airsupra |
| Exact Sciences Corporation | $54.96 | 2023-2025 | Cologuard Collection Kit |
| Corcept Therapeutics | $54.08 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.72 | 2020-2025 | Xifaxan |
| Lilly USA, LLC | $46.20 | 2019-2024 | Jardiance, Zepbound |
| Genentech USA, INC. | $43.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.43 | 2019-2020 | |
| Romark Laboratories, Lc | $36.86 | 2020 | |
| Ethicon INC. | $36.63 | 2024 | Monarch Platform |
| Abbott Laboratories | $31.83 | 2021-2025 | Freestyle Libre 3 |
| Evoke Pharma, INC. | $25.39 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.87 | 2019-2020 | |
| Ets Wound Care LLC | $20.94 | 2024 | Mirragen Advanced Wound Matrix |
| Jazz Pharmaceuticals INC. | $16.03 | 2022 | |
| Boston Scientific Corporation | $15.85 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.46 | 2022 | |
| Shire North American Group INC | $15.17 | 2019 | |
| Amgen INC. | $15.11 | 2020 | |
| Sanofi Pasteur INC. | $12.76 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.70 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.26 | 2019 | |
| Hologic Sales and Service, LLC | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.